An interstitial deletion within 9p21.3 and extending beyond <i>CDKN2A</i> predisposes to melanoma, neural system tumours and possible haematological malignancies.

Baker, Maria J; Goldstein, Alisa M; Gordon, Patricia L; Harbaugh, Kimberly S; Mackley, Heath B; Glantz, Michael J; Drabick, Joseph J

An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies.

Baker, Maria J; Goldstein, Alisa M; Gordon, Patricia L; Harbaugh, Kimberly S; Mackley, Heath B; Glantz, Michael J; Drabick, Joseph J.

Affiliation

Baker MJ; Department of Medicine, Penn State Milton S. Hershey Medical Center, Penn State Hershey Cancer Institute, Hershey, Pennsylvania, USA.
Goldstein AM; Division of Cancer Epidemiology and Genetics, Genetic Epidemiology Branch, National Cancer Institute, Bethesda, Maryland, USA.
Gordon PL; Department of Pediatrics, Penn State Milton S. Hershey Medical Center, Penn State Hershey Cancer Institute, Hershey, Pennsylvania, USA.
Harbaugh KS; Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, Penn State Hershey Cancer Institute, Hershey, Pennsylvania, USA.
Mackley HB; Department of Radiation Oncology, Penn State Milton S. Hershey Medical Center, Penn State Hershey Cancer Institute, Hershey, Pennsylvania, USA.
Glantz MJ; Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, Penn State Hershey Cancer Institute, Hershey, Pennsylvania, USA.
Drabick JJ; Department of Medicine, Penn State Milton S. Hershey Medical Center, Penn State Hershey Cancer Institute, Hershey, Pennsylvania, USA.

J Med Genet ; 53(11): 721-727, 2016 Nov.

Article in En | MEDLINE | ID: mdl-26794401